Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab

Development of effective therapies for recurrent glioblastoma multiforme (GBM) and reliable, timely evaluation of their benefit are needed. Understanding the relationship between objective response (OR) and survival is important for determining whether OR can provide an early signal of treatment act...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Prados, Michael, Cloughesy, Timothy, Samant, Meghna, Fang, Liang, Wen, Patrick Y., Mikkelsen, Tom, Schiff, David, Abrey, Lauren E., Yung, W.K. Alfred, Paleologos, Nina, Nicholas, Martin K., Jensen, Randy, Vredenburgh, James, Das, Asha, Friedman, Henry S.
格式: Artigo
語言:Inglês
出版: Oxford University Press 2011
主題:
Clinical Investigations
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3018914/
https://ncbi.nlm.nih.gov/pubmed/21084434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noq151
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍